ImaginAb

Schedule a meeting by visiting: https://lnkd.in/gbqx5v9k Meet our Sales team at the Society for Immunotherapy of Cancer (SITC) Annual Meeting at booth #630 on November 8th & 9th. Learn how you can use CD8 Imaging in your clinical trials. Schedule a meeting today! #CD8ImmunoPET #immunooncology #pharma #biotech #SITC24 #radiopharmaceutical #PETCT #nuclearmedicine #theranostics #RPT

ImaginAb is proud to support Breast Cancer Awareness Month. We are committed to advancing the fight against breast cancer through our research and partnerships. Here is a look at two collaborative research studies that focus on metastatic breast cancer research: Evaluating the immunologically “cold” tumor microenvironment after treatment with immune checkpoint inhibitors utilizing PET imaging of CD4+ and CD8+ T cells - https://lnkd.in/ghaiBSc9 Abstract PO1-20-12: CD8+ Tumor Infiltrating Lymphocytes Turn a Cold Tumor Hot in Metastatic Breast Cancer -https://lnkd.in/gEBVWMU8 Join us in raising awareness and supporting those affected by breast cancer. #ImaginAb #CD8ImmunoPET #RPT #biotech #theranostics #immunoonocology  #research #clinicaltrials #BreastCancerResearch #Pharmaceuticals #BreastCancerAwarenessDay

Read here: https://lnkd.in/g5gFrxJQ Dive into our latest article, "Pseudoprogression vs. True Progression in Immunotherapy: Challenges and Evaluation." Discover the complexities of distinguishing between pseudoprogression and true disease progression in the realm of immuno-oncology. Learn about the critical role of imaging techniques and the phenomenon of tumor flare. Don't miss out on this insightful read! Read here: https://lnkd.in/g5gFrxJQ #ImmunoOncology #CancerTreatment #Pseudoprogression #InnovationInHealthcare #CD8ImmunoPET #immunooncology #immunotherapy #oncology #medicalresearch

A huge thank you to the European Association of Nuclear Medicine (EANM) for organizing an incredible conference! The sessions were insightful, the networking opportunities were invaluable, and the overall experience was truly inspiring. We’re looking forward to next year’s meeting! #ImaginAb #CD8ImmunoPET #RPT #biotech #theranostics #immunoonocology  #research #clinicaltrials #Pharmaceuticals #EANM24 #EANM #EANM2024 #NuclearMedicine #Innovation

Schedule a meeting by visiting: https://lnkd.in/gbqx5v9k We are thrilled to announce that we will exhibit at this year’s Society for Immunotherapy of Cancer (SITC)’s 39th Annual Meeting! Our team is excited to connect with industry professionals and learn about the latest advancements in cancer research. Meet with Kristin Schmiedehausen, MD, Calmen Tihansky, Suzanne Bissonnette, Elizabeth Thomas and Clinique Burrell, MPA to get the latest updates on ImaginAb and CD8 ImmunoPET™. Visit us at booth #630 #CD8ImmunoPET #immunooncology #pharma #biotech #SITC24  #radiopharmaceutical #PETCT #nuclearmedicine #theranostics #RPT #ImaginAb

Check our latest Perspective’s blog by Matthew Hoover. Explore the transformative power of immuno-oncology therapies targeting CTLA-4, PD-1, and PD-L1, enhancing the immune system’s ability to fight tumors. While offering new hope, these treatments also present unique challenges, including immune-related adverse events (irAEs) that mirror autoimmune disorders and can impact any organ system. Early detection and management of irAEs are vital for patient outcomes. This blog delves into traditional and innovative methods for identifying irAEs, from clinical observation to advanced molecular imaging, ensuring optimized treatment and patient care. Read here: https://lnkd.in/gQgP4X99 #ImmunoOncology #CancerTreatment #irAEs #InnovationInHealthcare #CD8ImmunoPET #immunooncology #immunotherapy

Calmen Tihansky is attending Arena International Events Group's 16th Annual Outsourcing in Clinical Trials New England 2024 event on October 23 & 24th. Explore the potential of CD8 ImmunoPET™ in your clinical trials, by scheduling a meeting with Calmen by reaching out to him directly or email him at ctihansky@imaginab.com Industry experts will share their knowledge on various topics related to clinical trials, including clinical operations, outsourcing, technology, patient recruitment, and more. #CD8ImmunoPET #immunooncology #pharma #biotech #theranostics  #immunooncology #PETCT #nuclearmedicine #clinicaltrials #RareDiseases #Biopharma #ClinicalOperations #Innovation

Are you attending this year’s European Association of Nuclear Medicine (EANM) 27th Annual Congress? Be sure to schedule this top-rated oral presentation, “Dose Rates and Patient Contact Restrictions Following Zirconium 89 (Zr89) Positron Emission Tomography (PET) Studies” presented by Graham Wright, PhD, of Hull University Teaching Hospitals NHS Trust, UK This presentation highlights considerations around close contact guidelines for patients who have received Zr 89 crefmirlimab berdoxam. Connect with us at Booth # H04.C to learn more from our team attending: https://lnkd.in/gWPMeeX2 #ImaginAb #immunooncology #CD8ImmunoPET #biotech #pharma #EANM #EANM2024 #HullUniversityTeachingHospitals #NHSTrust 

We are excited to announce we are exhibiting at this year's European Association of Nuclear Medicine (EANM) 27th Annual Meeting. Connect with Gareth Smith, VP, Business Strategy, William Le, VP, Global Operations, Kristin Schmiedehausen, MD, VP, Medical Affairs, Michael Ferris, Associate Director, Operations and Oliver Brown, Radiopharmaceutical Supply Chain Manager who are attending. We look forward to connecting with delegates and learning about the latest in nuclear medicine and molecular imaging at this year’s conference. Visit us at booth # H04.C Schedule a meeting by visiting: https://lnkd.in/gWPMeeX2 #CD8ImmunoPET #immunooncology #pharma #biotech #EANM24 #ImaginAb #radiopharmaceutical #PETCT #nuclearmedicine #theranostics #RPT

Members of PINTad convened at this year’s ESMO - European Society for Medical Oncology Congress during a networking event organized by Sébastien Jacques and engaged in collaborative discussions on the role of imaging in clinical trials. The assembly included insightful contributors from Mint Medical, a Brainlab company, Radiomics.bio, Bayer, Median Technologies, RadMD , and many others. For further insights into using CD8 imaging within clinical trials, click here for more information: https://lnkd.in/gFXv3_ur #CD8ImmunoPET #immunooncology #immunotherapy #biotech #ESMO #ESMO2024 #radiology #PETCT #nuclearmedicine